Cancer Vaccine Triggers Immune System In Ovarian Cancer Study

July 26th, 2007 | Category: Cancer

A therapeutic ovarian cancer vaccine developed by researchers at Roswell Park Cancer Institute (RPCI) has shown promise in a phase I clinical trial. The results are published in the online Early Edition

(EE) of the Proceedings of the National Academy of Sciences, July 23-27. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Roswell Park Cancer Institute Receives Grant To Develop Vaccine Against Ovarian Cancer
  • Experimental Breast Cancer Vaccine Could Reduce Deaths By 50%, Researchers Say
  • ‘Enterprizing’ Vaccine For Rheumatoid Arthritis
  • Ovarian Cancer Vaccine Clinical Trial Begins At Cancer Treatment Centers Of America
  • Cancer Vaccine Moves A Step Closer

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.